Pacira BioSciences (PCRX) Return on Capital Employed Growth (1y) (2012 - 2026)
Pacira BioSciences (PCRX) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.83 Bn | 32.09 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 1,195.00 |
| 10 | Pacira BioSciences | 1.07 Bn | 862.96 Mn | 140.96 Mn | 888.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 888.00 |
| Dec 31, 2025 | 763.00 |
| Sep 30, 2025 | 825.00 |
| Jun 30, 2025 | -1,442.00 |
| Mar 31, 2025 | -1,374.00 |
| Dec 31, 2024 | -1,199.00 |
| Sep 30, 2024 | -817.00 |
| Jun 30, 2024 | 268.00 |
| Mar 31, 2024 | 437.00 |
| Dec 31, 2023 | 217.00 |
| Sep 30, 2023 | -154.00 |
| Jun 30, 2023 | -163.00 |
| Mar 31, 2023 | -261.00 |
| Dec 31, 2022 | -368.00 |
| Sep 30, 2022 | -475.00 |
| Jun 30, 2022 | -339.00 |
| Mar 31, 2022 | 59.00 |
| Dec 31, 2021 | 287.00 |
| Sep 30, 2021 | 631.00 |
| Jun 30, 2021 | 659.00 |